미국의 약물 검사 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 검체별, 약물별, 최종 용도별 및 부문별 예측(2026-2033년)

U.S. Drug Testing Market Summary

The U.S. drug testing market size was estimated at USD 2.62 billion in 2025, projected to reach USD 4.13 billion by 2033, expanding at a CAGR of 5.89% from 2026 to 2033. The growth of the market is driven by rising prevalence of substance abuse, stringent regulations requiring drug & alcohol testing, and growing government efforts to curb substance abuse in the U.S.

According to the Substance Abuse and Mental Health Services Administration (SAMHSA) 2024 national survey on drug use and health, about 73.6 million Americans aged twelve or older (25.5%) reported using illicit drugs in the past year. Cannabis remains the commonly used illicit drug, with around 64.2 million users, followed by substances such as hallucinogens, prescription opioids, and cocaine.

Furthermore, growing emphasis on workplace safety and compliance across industries is also supporting the expansion of the U.S. drug testing market. Many employer liability issues are driving the adoption of pre-employment, random, and post-incident drug testing programs, supporting market demand. The expansion of drug testing across workplaces and healthcare settings further contributes to growth. Moreover, the U.S. government actively promotes national campaigns to raise awareness about the dangers of substance abuse. Programs such as "National Drug & Alcohol Facts Week" and the DEA's educational outreach provide schools, communities, and workplaces with resources to prevent drug misuse.

The increasing prevalence of substance abuse in the U.S. has significantly raised the demand for drug testing solutions. The ongoing opioid crisis has also increased the need for monitoring and testing programs across healthcare, workplace, and law enforcement sectors. According to the Centers for Disease Control and Prevention (CDC), the U.S. recorded over 107,000 drug overdose deaths in 2023, highlighting the serious public health impact of drug misuse. These rising cases of substance misuse and overdose are encouraging governments, employers, and healthcare providers to adopt regular drug screening and monitoring programs, which is supporting the growth of the U.S. drug testing market.

U.S. Drug Testing Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the U.S. drug testing market report on the basis of test, application, and end use.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Consumables
  • Instruments
  • Rapid Testing Devices
  • Services
• Sample Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Urine Samples
  • Oral Fluid Samples
  • Hair Samples
  • Other Samples
• Drug Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Alcohol
  • Cannabis/Marijuana
  • Cocaine
  • Opioids
  • Amphetamine & Methamphetamine
  • LSD
  • Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug Testing Laboratories
  • Workplaces
  • Hospitals
  • Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Sample type
  • 1.2.3. Drug type
  • 1.2.4. End use
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Objectives
  • 1.3.1. Objective-1
  • 1.3.2. Objective-2
  • 1.3.3. Objective-3
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased database
  • 1.5.2. GVR's internal database
  • 1.5.3. Secondary sources
  • 1.5.4. Primary research
• 1.6. Information or Data Analysis
  • 1.6.1. Data analysis models
• 1.7. Market Formulation & Validation
• 1.8. Model Details
  • 1.8.1. Commodity flow analysis
    • 1.8.1.1. Approach 1: Commodity flow approach
    • 1.8.1.2. Approach 2: Country-wise market estimation using bottom-up approach
• 1.9. List of Secondary Sources
• 1.10. List of Primary Sources
• 1.11. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Product Snapshot
• 2.3. Sample Snapshot
• 2.4. Drug and End-use Snapshot
• 2.5. Competitive Insights

Chapter 3. U.S. Drug Testing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook (Drug Testing Market)
  • 3.1.2. Related/ancillary market outlook (Drug Screening Market)
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising prevalence of substance abuse
    • 3.2.1.2. Stringent regulations requiring drug and alcohol testing
    • 3.2.1.3. Growing government efforts to curb substance abuse
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Stringent regulatory framework for drug testing products
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Expansion of testing in new industries
    • 3.2.3.2. Policies like the Affordable Care Act (ACA)
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Economic Downturns
    • 3.2.4.2. Reduction in corporate spending
• 3.3. U.S. Drug Testing Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape
• 3.4. Regulatory Framework
• 3.5. Reimbursement Scenario

Chapter 4. U.S. Drug Testing Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Drug Testing Market: Product Movement Analysis
• 4.3. U.S. Drug Testing Market by Product Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 4.5. Consumables
  • 4.5.1. Consumables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.2. Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Instruments
  • 4.6.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.2. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Rapid Testing Devices
  • 4.7.1. Rapid Testing Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7.2. Rapid Testing Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Services
  • 4.8.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8.2. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Drug Testing Market: Sample Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Drug Testing Market: Sample Type Movement Analysis
• 5.3. U.S. Drug Testing Market by Sample Type Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 5.5. Urine Samples
  • 5.5.1. Urine Samples Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.2. Urine Samples Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
• 5.6. Oral Fluid Samples
  • 5.6.1. Oral Fluid Samples Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.2. Oral Fluid Samples Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Hair Samples
  • 5.7.1. Hair Samples Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7.2. Hair Samples Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Other Sample
  • 5.8.1. Other Sample Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8.2. Other Sample Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Drug Testing Market: Drug Type Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Drug Testing Market: Drug Type Movement Analysis
• 6.3. U.S. Drug Testing Market by Drug Type Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 6.5. Alcohol
  • 6.5.1. Alcohol Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.2. Alcohol Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Cannabis/Marijuana
  • 6.6.1. Cannabis/Marijuana Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.2. Cannabis/Marijuana Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Cocaine
  • 6.7.1. Cocaine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.2. Cocaine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Opioids
  • 6.8.1. Opioids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8.2. Opioids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.9. Amphetamine & Methamphetamine
  • 6.9.1. Amphetamine & Methamphetamine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9.2. Amphetamine & Methamphetamine Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
• 6.10. LSD
  • 6.10.1. LSD Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.10.2. LSD Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
• 6.11. Others
  • 6.11.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.11.2. Others Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 7. U.S. Drug Testing Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. U.S. Drug Testing Market: End Use Movement Analysis
• 7.3. U.S. Drug Testing Market by End Use Outlook (USD Million)
• 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 7.5. Drug Testing Laboratories
  • 7.5.1. Drug Testing Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. Drug Testing Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
• 7.6. Workplaces
  • 7.6.1. Workplaces Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Workplaces Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
• 7.7. Hospitals
  • 7.7.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
• 7.8. Others
  • 7.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.2. Others Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Recent Developments & Impact Analysis by Key Market Participants
• 8.3. Company Market Share Analysis, 2025
• 8.4. Key Company Profiles
  • 8.4.1. Quest Diagnostics Incorporated
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Abbott
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Laboratory Corporation of America Holdings (Labcorp)
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. Thermo Fisher Scientific, Inc.
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. OraSure Technologies, Inc.
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. Psychemedics Corporation
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Omega Laboratories, Inc
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Premier Biotech, Inc
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Alfa Scientific Designs, Inc
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives